Ironwood Pharma Files 2024 10-K
Ticker: IRWD · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1446847
| Field | Detail |
|---|---|
| Company | Ironwood Pharmaceuticals Inc (IRWD) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, annual-report
TL;DR
Ironwood Pharma dropped its 2024 10-K. All the deets on their biz for last year.
AI Summary
Ironwood Pharmaceuticals, Inc. filed its 2024 10-K on March 31, 2025, detailing its financial performance and business operations for the fiscal year ending December 31, 2024. The company, headquartered in Boston, MA, operates within the pharmaceutical preparations industry. The filing provides comprehensive information on its financial condition, results of operations, and risk factors.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Ironwood Pharmaceuticals' financial health and strategic direction for the past fiscal year, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Ironwood is subject to inherent risks including regulatory changes, clinical trial outcomes, and market competition.
Key Players & Entities
- IRONWOOD PHARMACEUTICALS INC (company) — Filer
- 0001446847 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification
- 001-34620 (company) — SEC File Number
- 100 SUMMER STREET, SUITE 2300 (company) — Business Address
- BOSTON (company) — City
- MA (company) — State
- 02110 (company) — ZIP Code
- 617-621-7722 (company) — Business Phone
- 20241231 (date) — Fiscal Year End
FAQ
What is Ironwood Pharmaceuticals' primary industry classification?
Ironwood Pharmaceuticals, Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on March 31, 2025.
What is the fiscal year end for Ironwood Pharmaceuticals?
The fiscal year end for Ironwood Pharmaceuticals is December 31.
What is the company's business address?
The business address is 100 Summer Street, Suite 2300, Boston, MA 02110.
What is the SEC file number for Ironwood Pharmaceuticals?
The SEC file number is 001-34620.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding IRONWOOD PHARMACEUTICALS INC (IRWD).